ImmunityBio, Inc. (IBRX) › Shares OutstandingImmunityBio, Inc. (IBRX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2015: 81.31M2016: 81.98M2017: 79.02M2018: 79.09M2019: 98.46M2020: 382.24M2021: 397.83M2022: 421.57M2023: 670.87M2024: 852.90M2025: 1.01B1.01B2015Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY20251.01B+18.6%2024852.90M+27.1%2023670.87M+59.1%2022421.57M+6.0%2021397.83M+4.1%2020382.24M+288.2%201998.46M+24.5%201879.09M+0.1%201779.02M-3.6%201681.98M+0.8%201581.31M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share